Inauguration Day: The defining images as Joe Biden becomes US president
At noon on 20 January 2021, the tumultuous and divisive Trump term ended and Joe Biden, the former VP and longtime senator with working-class Scranton roots, became the 46th president of the United States.
The swearing-in ceremony on Wednesday was a stark reminder of the uphill challenges that the new president faces in office.
Washington DC is surrounded by a ring of steel and troops reminiscent of a war zone following an insurrectionist siege at the US Capitol by a pro-Trump mob earlier this month. And the capital, normally packed with jubilant scenes on such a historic occasion, is strangely empty due to pandemic precautions.
Here, The Independent, takes a look at the defining images on the day that the Biden era began.
Shares of LivePerson (NASDAQ: LPSN) have soared today, up by 15% as of 2:45 p.m. EST, after the company reported fourth-quarter earnings. Revenue in the fourth quarter increased 29% to $102.1 million, ahead of the consensus estimate of $99.2 million. The technology company, which specializes in conversational commerce software, said that it inked 128 new contracts during the quarter, including 10 deals worth over $1 million.
ABC News is premiering a six-episode series on Tuesday that is being promoted as something far different for traditional network newsmagazine: Soul of a Nation focuses on the Black experience in America, or as ABC News executive Marie Nelson put it on Friday, “The series expands the vision of Black life in America in a […]
The snow and ice rally, based in Rovaniemi, is the second round of the season and the first time the championship has ventured within the Arctic Circle. Tanak won the first stage by 3.6 seconds and was then almost 10 faster than anyone else in the next one run in the evening dark. "This has been a rollercoaster kind of day, typical for Finland with very technical and up-and-down roads," added the 2019 world champion.
Europe's medicines regulator on Friday provisionally approved use of US biotech firm Regeneron's Covid-19 therapy, saying it prevented patients from getting worse. Regeneron's synthetic antibody treatment was used to treat former US President Donald Trump after he contracted coronavirus last year.The European Medicines Agency said preliminary results showed treatment with REGN-COV2 reduced the amount of the virus in the back of the nose and throat and led to fewer medical visits."The Agency concluded that... REGN-COV2 can be used for the treatment of confirmed Covid-19 in patients who do not require supplemental oxygen and who are at high risk of progressing to severe Covid-19," it said in a statement.REGN-COV2 is a combination of casirivimab and imdevimab, two monoclonal antibodies which is given to a patient via a drip, the EMA said.Monoclonal antibodies are lab-made versions of the body's natural infection-fighting defenses.The two antibodies have been designed to attach to the spike protein of the coronavirus at two different sites, stopping it from entering the body's cells, the EMA said.A rolling review of the two antibodies, which started on February 1 "was ongoing", the medicines regulator said, adding "once finalised it will be the basis for an EU marketing authorisation for this combination".The US-based Food and Drug Administration in November approved emergency use of REGN-COV2, experimentally used to treat Trump.On Thursday, France too announced it had distributed thousands of monoclonal antibody treatments to hospitals, with Health Minister Olivier Veran saying "there are new hopes... which strengthen our anti-Covid arsenal".The EMA however did not make an announcement Friday on the approval of Johnson & Johnson's coronavirus jab, which earlier this month applied for authorisation within the European Union.So far, three vaccines made by Pfizer/BioNTech, Moderna and AstraZeneca have been approved by the EMA.A US panel of independent experts were meeting Friday to discuss whether to grant J&J's covid shot the go-ahead in the United States.Friday's announcements followed the Amsterdam-based EMA's monthly meeting, where it also recommended the approval of six other medicines including the first oral treatment for patients with certain types of spinal muscular atrophy.This rare and often fatal genetic disease causes muscle weakness and progressive loss of movement.(AFP)
The Nasdaq Composite (NASDAQINDEX: ^IXIC) got some much-needed relief on Friday, with the market benchmark finally regaining a little bit of ground after a brutal sell-off that lasted much of the week. As of 2:30 p.m. EST, the Nasdaq was still up about half a percent, although that was well below where it had been at its highs. Many investors think of the Nasdaq as being synonymous with technology stocks, and it's definitely true that many of the companies with the most weight and influence in the Nasdaq do indeed have ties to tech.
The need for these chips has boomed in recent years, coinciding with an explosion in automotive technology, driveline components, and interior infotainment systems. The chip shortage is about to hit Ford Motor Company's (NYSE: F) European operations in a big way. More specifically, the chip shortage will force Ford's factory in Saarlouis, Germany to halt production for five weeks.
EXCLUSIVE: Amazon Studios is developing Am I There Yet? a comedy series based on Mari Andrew’s bestselling semi-autobiographical book, from writer Camilla Blackett (Skins) and Rachel Brosnahan’s Scrap Paper Pictures. Written by Blackett, Am I There Yet? is a soulful, honest and optimistic guide to growing up, capturing all the feelings and comical complexities of […]